(Press-News.org) CHICAGO, IL—Researchers have developed a device that uses any smartphone to measure the cortisol concentration in saliva. The device was presented Tuesday, June 24, at ICE/ENDO 2014, the joint meeting of the International Society of Endocrinology and the Endocrine Society in Chicago.
"We have developed a method for measuring cortisol in saliva using a smartphone and a disposable test strip. This innovation enables anyone with a smartphone to measure their salivary cortisol level quickly, accurately, and affordably," said lead study author Joel R. L. Ehrenkranz, MD, director of diabetes and endocrinology of the Department of Medicine at Intermountain Healthcare in Murray, Utah.
Cortisol is a hormone made by the adrenal glands that's essential for the body's response to stress, and measuring cortisol can help diagnose adrenal diseases and monitor stress levels. Current testing for salivary cortisol levels involves collecting a saliva sample and sending it to a clinical lab for analysis.
"A lab charges about $25 to $50 for a quantitative salivary cortisol test and has a turnaround time of days to a week. This test, taken in a medical office or at home, will cost less than $5 and take less than 10 minutes," Dr. Ehrenkranz said. "The device is a reader that includes a case, a light pipe, and a lens and costs about a dollar to make. There is no battery power and it's unbreakable, passive and reusable."
Doctors worldwide can use the smartphone test to help them diagnose adrenal insufficiency and hypercortisolism and monitor physiologic variations in cortisol concentration; and individuals can monitor their own cortisol levels whenever they like.
The software is "operating-system-agnostic," he explained, meaning that the device can be used on all platforms, including iOS, Android, Windows, and BlackBerry, and it has a universal form factor that works with all smartphones.
The person being tested inserts a straw-like saliva collector under the tongue. The collector wicks the saliva by capillary action to an immunoassay strip housed in a cassette and the cassette is inserted into the reader. The smartphone uses its camera and flash to take a picture of the saliva-coated strip and an algorithm converts the image's pixel density to a cortisol value.
Marketing this test as a cortisol assay would make it a class 2 medical device, Dr. Ehrenkranz explained. He and his research team are now collecting clinical data for the FDA submission, and hope to attain approval in 2015.
INFORMATION:
This study was privately funded.
Founded in 1916, the Endocrine Society is the world's oldest, largest and most active organization devoted to research on hormones and the clinical practice of endocrinology. Today, the Endocrine Society's membership consists of over 17,000 scientists, physicians, educators, nurses and students in more than 100 countries. Society members represent all basic, applied and clinical interests in endocrinology. The Endocrine Society is based in Washington, DC. To learn more about the Society and the field of endocrinology, visit our site at http://www.endocrine.org. Follow us on Twitter at https://twitter.com/#!/EndoMedia.
Quick, easy, inexpensive cortisol testing should soon be available on all smartphones
2014-06-24
ELSE PRESS RELEASES FROM THIS DATE:
Sweet sweet straw
2014-06-24
This news release is available in German. Erythritol has many great advantages: it does not make you fat, it does not cause tooth decay, it has no effect on the blood sugar and, unlike other sweeteners, it does not have a laxative effect. In Asia it is already widely used and it is becoming more and more common in other parts of the world too. Up until now, erythritol could only be produced with the help of special kinds of yeast in highly concentrated molasses. At the TU Vienna, a method has now been developed to produce the sweetener from ordinary straw with the help ...
Expert outlines challenges of visual accessibility for people with low vision
2014-06-24
June 24, 2014 – New approaches and tools are needed to improve visual accessibility for people with low vision in the "real world," according to a special article in the July issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Vision science, in collaboration with other professions, has a key role in developing technologies and design approaches to promote visual accessibility for the millions of people living with low vision, according ...
Experts cite 'misconceptions' on brain metastases
2014-06-24
June 24, 2014 – "Key historical misconceptions" are hindering progress in research and treatment for patients with cancer metastases to the brain, suggests a special article in the July issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Dr. Douglas Kondziolka of NYU Langone Medical Center and coauthors identify some issues that may be standing in the way of optimal clinical management for patients with cancer that has spread to the brain from other ...
New transdermal SARM drug for muscle-wasting offers hope for older cancer patients
2014-06-24
CHICAGO, IL—Muscle wasting that occurs as a result of cancer negatively impacts the well-being and recovery prospects of millions of patients, particularly the rapidly-growing elderly populations in Western societies. Drugs called selective androgen receptor modulators (SARMs) offer hope for these patients, and a new SARM for transdermal administration is promising excellent efficacy without harming liver function and HDL levels. Results and conclusions were presented Tuesday at the joint meeting of the International Society of Endocrinology and the Endocrine Society: ICE/ENDO ...
Gender differences could mean more risk for cardiovascular death
2014-06-24
Queen's University assistant professor Pendar Farahani (Department of Medicine and Department of Public Health Sciences) is advocating the use of gender-based treatment for mitigating the cardiovascular risk factors related to diabetes.
Research has shown women with Type 2 diabetes and high cholesterol are less likely than their male peers to reach treatment goals to lower their bad cholesterol, or low-density lipoprotein (LDL) cholesterol.
"The findings suggest the need for gender-based evaluation and treatment of cardiovascular risk factors in these patients," says ...
Study finds high CD4 cell counts associated with reduced risk of ischemic stroke for those with HIV
2014-06-24
OAKLAND, Calif., June 24, 2014 — A 15-year study found that HIV-positive individuals had a 40 percent increased risk of ischemic stroke, however stroke rates were nearly the same for HIV-positive individuals with high CD4 cell counts as for HIV-negative subjects.
The study, published recently in AIDS, the official journal of the International AIDS Society, covered the years 1996 through 2011 and included nearly 25,000 HIV-positive individuals.
Ischemic stroke is caused by plaque build-up in blood vessels, which can lead to constriction or actual obstruction of blood ...
Bizarre parasite from the Jurassic
2014-06-24
Around 165 million years ago, a spectacular parasite was at home in the freshwater lakes of present-day Inner Mongolia (China): A fly larva with a thorax formed entirely like a sucking plate. With it, the animal could adhere to salamanders and suck their blood with its mouthparts formed like a sting. To date no insect is known that is equipped with a similar specialised design. The international scientific team is now presenting its findings in the journal "eLIFE".
The parasite, an elongate fly larva around two centimeters long, had undergone extreme changes over the ...
Aging accelerates genomic changes, signaling challenges for personalized medicine
2014-06-24
Exploiting individual genomes for personalized medicine may be more complicated than medical scientists have suspected, researchers at the Virginia Bioinformatics Institute of Virginia Tech have discovered.
In a paper published in June in the journal Aging, scientists from the institute's Medical Informatics and Systems Division found that spontaneous mutations occur in our bodies constantly, but the rate of change differed dramatically among various people.
The study has implications for personalized medicine, which will make use of genomic information to predict future ...
Young women with PCOS are 5 times more likely to develop type 2 diabetes
2014-06-24
A leading expert on reproductive health says young women with Polycystic Ovary Syndrome (PCOS) have a startlingly higher risk of developing type 2 diabetes, even if young and not overweight.
The research led by Professor Helena Teede and Dr Anju Joham, from the School of Public Health and Preventive Medicine at Monash University analysed a large-scale epidemiological study, called the Australian Longitudinal Study of Women's Health, which revealed the findings.
Over 6000 women aged between 25-28 years were monitored for nine years, including 500 with diagnosed PCOS. ...
New possibilities for leukemia therapy with a novel mode of leukemia cell recognition
2014-06-24
Singapore, 24 June 2014—Scientists at A*STAR's Singapore Immunology Network (SIgN) have discovered a new class of lipids in the leukaemia cells that are detected by a unique group of immune cells. By recognising the lipids, the immune cells stimulate an immune response to destroy the leukaemia cells and suppress their growth. The newly identified mode of cancer cell recognition by the immune system opens up new possibilities for leukaemia immunotherapy .
Leukaemia is characterized by the accumulation of cancer cells originating from blood cells, in the blood or bone marrow. ...